Literature DB >> 8369687

Erythema multiforme following substitution of amlopidine for nifedipine.

A P Bewley1, M D Feher, R C Staughton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8369687      PMCID： PMC1678146          DOI： 10.1136/bmj.307.6898.241-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.

Authors:  H L Chan; R S Stern; K A Arndt; J Langlois; S S Jick; H Jick; A M Walker
Journal:  Arch Dermatol       Date:  1990-01

Review 2.  Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

Authors:  D Murdoch; R C Heel
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

3.  Comparison of early side effects with amlodipine and nifedipine retard in hypertension.

Authors:  J Hosie; A D Bremner; P J Fell; I G James; P A Saul; S H Taylor
Journal:  Cardiology       Date:  1992       Impact factor: 1.869
  3 in total
  4 in total

1.  Lichenoid eruption associated with cinnarizine use.

Authors:  María Ramallal; Miguel Gallego; Teresa Bermejo; Benito García
Journal:  Pharm World Sci       Date:  2002-12

2.  Rumpel-leede phenomenon in a hypertensive lady on amlodipine.

Authors:  Kandan Balamurugesan; Stalin Viswanathan
Journal:  J Clin Diagn Res       Date:  2014-04-15

Review 3.  A comparative review of the adverse effects of calcium antagonists.

Authors:  H T Dougall; J McLay
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 4.  Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.

Authors:  M Haria; A J Wagstaff
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.